Skip to main content
Christopher Tinkle, MD, Radiation Oncology, Memphis, TN

ChristopherLonTinkleMDPhD

Radiation Oncology Memphis, TN

Pediatric Radiation Oncology

Assistant Member, St. Jude Children's Research Hospital

Dr. Tinkle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Tinkle's full profile

Already have an account?

  • Office

    262 Danny Thomas Pl
    Memphis, TN 38105
    Phone+1 888-226-4343

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Radiation Oncology, 2011 - 2015
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2010

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - Present
  • TN State Medical License
    TN State Medical License 2015 - 2025
  • American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG.  
    30. Chiang J, Diaz AK, Makepeace L, Li X, Han Y, Li Y, Klimo P Jr, Boop FA, Baker SJ, Gajjar A, Merchant TE, Ellison DW, Broniscer A, Patay Z, Tinkle CL., Acta Neuropathol Commun, 4/23/2020
  • MRI Patterns of Extrapontine Lesion Extension in Diffuse Intrinsic Pontine Gliomas  
    27. Makepeace L, Scoggins M, Mitrea B, Li Y, Edwards A, Tinkle CL, Hwang S, Gajjar A, Patay Z., J Neuroradio, 2/4/2020
  • Association between hippocampal dose and memory in survivors of childhood or adolescent low-grade glioma: a 10-year neurocognitive longitudinal study  
    Acharya S, Wu S, Ashford JM, Tinkle CL, Lucas JT, Qaddoumi I, Gajjar A, Krasin MJ, Conklin HM, Merchant TE., Neuro Oncol., 4/12/2019
  • Join now to see all

Press Mentions

  • Kazia Presents Further Paxalisib Data at Sno, Confirming Earlier Positive Safety and Efficacy Signals in Glioblastoma
    Kazia Presents Further Paxalisib Data at Sno, Confirming Earlier Positive Safety and Efficacy Signals in GlioblastomaNovember 18th, 2020
  • St. Jude Children’s Research Hospital Completes Initial Stage of Phase I Trial Assessing GDC-0084 for Deadly Pediatric Brain Tumor
    St. Jude Children’s Research Hospital Completes Initial Stage of Phase I Trial Assessing GDC-0084 for Deadly Pediatric Brain TumorSeptember 16th, 2019
  • St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway
    St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now UnderwaySeptember 12th, 2019